The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level
Open accessAbstract
BCL11A Variants: Recent chromatin mapping data have suggested that trait-associated variants often mark regulatory DNA. However, there has been little rigorous experimental investigation of regulatory variation. Bauer et al. (p. 253 ; see the Perspective by Hardison and Blobel ) performed an in-depth study of the BCL11A fetal hemoglobin-associated locus. The trait-associated variants revealed a chromatin signature that enhanced erythroid development. The enhancer was required for erythroid expression of BCL11A and thus for globin gene expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This enhancer consists of 3 DNase hypersensitive sites 162, 158, and 155 kb from the transcription initiation site.19”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [19]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Genomewide association studies have identified single-nucleotide polymorphisms (SNPs) associated with increased expression of fetal hemoglobin in adults.26”
From CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia (2021) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“Functional variants of BCL11A are marked by single nucleotide polymorphisms (SNPs) in intron 2 that tag an erythroid-specific enhancer.19”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“The sentinel SNP marking this QTL is rs1427407.”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Systematic Localization of Common Disease-Associated Variation in Regulatory DNA
Maurano, M. T., Humbert, R., Rynes, E., Thurman, R. E., Haugen, E., Wang, H., Reynolds, A. P., Sandstrom, R., Qu, H., Brody, J., et al. (2012) · Science · doi:10.1126/science.1222794 · Cited by 3,716
Self-citationMapping and analysis of chromatin state dynamics in nine human cell types
Ernst, J., Kheradpour, P., Mikkelsen, T. S., Shoresh, N., Ward, L. D., Epstein, C. B., Zhang, X., Wang, L., Issner, R., Coyne, M., et al. (2011) · Nature · doi:10.1038/nature09906 · Cited by 2,898
The accessible chromatin landscape of the human genome
Thurman, R. E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M. T., Haugen, E., Sheffield, N. C., Stergachis, A. B., Wang, H., Vernot, B., et al. (2012) · Nature · doi:10.1038/nature11232 · Cited by 2,679
Self-citationRare-Variant Association Testing for Sequencing Data with the Sequence Kernel Association Test
Wu, M. C., Lee, S., Cai, T., Li, Y., Boehnke, M., & Lin, X. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.029 · Cited by 2,373
Genome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
A TALE nuclease architecture for efficient genome editing
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098
Čermák, T., Doyle, E., Christian, M. L., Wang, L., Zhang, Y., Schmidt, C. L., Baller, J. A., Somia, N. V., Bogdanove, A. J., & Voytas, D. F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr218 · Cited by 2,034
TALENs: A widely applicable technology for targeted genome editing
Joung, J. K., & Sander, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3486 · Cited by 1,650
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 656
Multi-Locus Models to Address Hb F Variability in Portuguese β-Thalassemia Carriers
Manco, L., Bento, C., Relvas, L., Cunha, E., Pereira, J., Moreira, V., Álvarez, M., Maia, T. M., & Ribeiro, M. L. (2020) · Hemoglobin · doi:10.1080/03630269.2020.1753766 · Cited by 3
MMCT-Loop: a mix model-based pipeline for calling targeted 3D chromatin loops
Tang, L., Liao, J., Hill, M., Hu, J., Zhao, Y.-C., Ellinor, P., & Li, M. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae029 · Cited by 3
DNA regulatory element cooperation and competition in transcription
Lee, H., Friedman, M. J., Kim, S. B., & Oh, S. (2024) · BMB Reports · doi:10.5483/bmbrep.2024-0069 · Cited by 4
Role of B-Cell Lymphoma/Leukemia 11A in Normal and Malignant Hematopoiesis
Zhang, H., Zeng, J., Zhang, F., Liu, J., & Liang, L. (2025) · Biology · doi:10.3390/biology14010026 · Cited by 4
Exome sequencing in high and low fetal haemoglobin Arab–Indian haplotype sickle cell disease
Al-Nafie, A. N., Al-Ateeq, S., Al‐Muhanna, F., Alsulaiman, A. M., Alfarhan, M. F. A., Buali, W., Vatte, C., Cyrus, C., Keating, B. J., Al‐Ali, A. K., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17542 · Cited by 3
Human genome editing as a tool to establish causality
Urnov, F. D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322645111 · Cited by 3
Ranjbar, M., Amiri, F., Nourigorji, M., Torabizadeh, F., Dara, M., & Dianatpour, M. (2022) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-022-00267-z · Cited by 3
Learning about mammalian gene regulation from functional enhancer assays in the mouse
Nord, A. S. (2015) · Genomics · doi:10.1016/j.ygeno.2015.06.008 · Cited by 3
Laugsch, M., Bartusel, M., Alirzayeva, H., Karaolidou, A., Rehimi, R., Crispatzu, G., Nikolić, M., Bleckwehl, T., Kolovos, P., van IJcken, W. F. J., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3155617 · Cited by 3
ATF4 mediates fetal globin upregulation in response to reduced β-globinPreprint
Boontanrart, M. Y., Stehli, G., Banović, M., Schröder, M., Wyman, S. K., Lew, R., Bordi, M., Gowen, B. G., DeWitt, M. A., & Corn, J. E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.15.905943 · Cited by 3
Xiang, G., He, X., Giardine, B. M., Isaac, K. J., Taylor, D. J., McCoy, R. C., Jansen, C. S., Keller, C. A., Wixom, A. Q., Cockburn, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.02.535219 · Cited by 3
Scalable assessment of genome editing off-targets associated with genetic variantsPreprint
Lin, J., Nguyen, M. A., Lin, L. Y., Zeng, J., Verma, A., Neri, N. R., da Silva, L. F., Mucci, A., Wolfe, S. A., Shaw, K. L., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.24.605019 · Cited by 3
Self-citationRivest, J.-F., Carter, S., Goupil, C., Antérieux, P., Cyr, D., Ung, R., Soglio, D. B. D., Mac‐Way, F., Waters, P. J., Paganelli, M., et al. (2024) · Genetics · doi:10.1093/genetics/iyae139 · Cited by 3
MYB represses ζ-globin expression through upregulating ETO2
Dong, Z., Ye, Y., Zhang, W., Luo, H., Li, J., Zhang, Q., Zhang, X., Guo, X., & Xu, X. (2024) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2024239 · Cited by 2
Aprile, A., Lidonnici, M. R., & Ferrari, G. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102419 · Cited by 2
Engineered ADARs enable precision A-to-G base editing of DNA
Im, H. W., Jeong, B., Lee, Y., Oh, Y. E., Jung, C., Kim, Y. W., Kim, D. Y., Lee, S., Uhm, H., Kim, Y., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03223-z · Cited by 3
Brancaleoni, V., Moukhadder, H. M., Consonni, D., Koussa, S., Pierro, E. D., Cappellini, M. D., & Taher, A. T. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3567-3 · Cited by 3
Genome Editing and Hematologic Malignancy
Emmer, B. T., & Ginsburg, D. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-052318-100741 · Cited by 2
BCL11A Polymorphism in Egyptian Children with β-Thalassemia: Relation to Phenotypic Heterogeneity
Salah, N. Y., Ali, H. G. A., Bassiouny, N., Salem, L. E. M. A., Taha, S., Youssef, M. K., Annaka, L., & Barakat, N. M. (2021) · Journal of Pediatric Genetics · doi:10.1055/s-0041-1728744 · Cited by 3
Recent advances of CRISPR/Cas9 gene editing in the treatment of β-thalassemia
Xie, Q., Lei, S.-Y., Qu, C., Wu, H., Liu, Y., Huang, P., & Teng, S. (2022) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2022-0109 · Cited by 2
Hub Gene Screening Associated with Early Glaucoma: An Integrated Bioinformatics Analysis
Tian, R., Li, F., Che, S., Song, M., Liu, L., Guo, R., Li, Z., Hu, X., & Zhang, H. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/8030243 · Cited by 2
RetractedFrom genome-wide association study hits to new insights into experimental hematology
Cvejic, A. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.04.005 · Cited by 2
Gene Therapy for Hemoglobinopathies
Dong, A., Breda, L., & Rivella, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800563-7.00012-9 · Cited by 3
Chen, J., & Guo, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-00583-1 · Cited by 2
Aghaa, O. B., & Hamad, H. T. (2022) · Military Medical Science Letters · doi:10.31482/mmsl.2022.007 · Cited by 2
The Novel Role of the B-Cell Lymphoma/Leukemia 11A (BCL11A) Gene in β-Thalassaemia Treatment
Lai, M. I., & Ahmed, N. H. M. (2022) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x23666230123140926 · Cited by 3
Suwito, B. E., Adji, A. S., Widjaja, J. S., Angel, S. C. S., Hajiri, A. Z. Z. A., Salamy, N. F. W., & Choirotussanijjah, C. (2023) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2023.11435 · Cited by 3
Applications of CRISPRi and CRISPRa in Drug Discovery
Gilbert, L. A. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch10 · Cited by 2
Genome editing coming of age for hemoglobinopathy
Jiang, H. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.007 · Cited by 2
Expansion of human hematopoietic stem cells by inhibiting translationPreprint
Li, C., Shin, H., Bhavanasi, D., Liu, M., Yu, X., Liu, X., Herbst, F., Alameh, M.-G., Breda, L., Kovuru, N., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.28.568925 · Cited by 3
Freimann, K., Brümmer, A., Warmerdam, R., Rupall, T. S., Hernández-Ledesma, A. L., Chiou, J., Holzinger, E. R., Maranville, J., Nakić, N., Ongen, H., et al. (2024) · medRxiv · doi:10.1101/2024.07.15.24310442 · Cited by 2
The Impact of BCL11A Polymorphisms on Endometrial Cancer Risk Among Chinese Han Females
Cai, J., Peng, S., Wang, H., & Bao, S. (2022) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s345772 · Cited by 1
Shu, Y., Chen, X., Wei, Z., & Chen, C.-Y. (2025) · SAGE Open Medical Case Reports · doi:10.1177/2050313x251314069 · Cited by 1
Une approche CRISPR/Cas pour traiter les β-hémoglobinopathies
Brusson, M., & Miccio, A. (2025) · médecine/sciences · doi:10.1051/medsci/2024191 · Cited by 2
Lavazec, C., Loucoubar, C., Dupuy, F., Bureau, J., Casadémont, I., Gonçalves, B. P., Thein, S. L., Lathrop, M. G., Laurance, S., Roussel, C., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325797 · Cited by 1
Shan, X., Li, Q., Wang, M., Niu, Y., Sun, Z., Ma, X., Wang, T., Tong, X., Zhang, J., & Niu, D. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01756-1 · Cited by 1
Fetal Hemoglobin Research and Clinical Relevance in Sickle Cell Disease
Gudmundsdóttir, B. K., & Tisdale, J. F. (2025) · Physiology · doi:10.1152/physiol.00024.2025 · Cited by 1
An intergenic silencer region regulates HBG expression
Zhu, X., Liu, L., Li, Y., Takezaki, M., Bombin, S., Yu, A., Pendergast, M. A., Sheehan, V., Kuppers, D. A., Bleris, L. G., et al. (2026) · Blood Red Cells & Iron · doi:10.1016/j.brci.2026.100046 · Cited by 1
HbF-inducing gene therapies for the β-hemoglobinopathies: implications for future pregnancies
Gavillet, M., Legardeur, H., Adam, C. J. M., Renella, R., Dashraath, P., & Baud, D. (2026) · Blood Red Cells & Iron · doi:10.1016/j.brci.2026.100047 · Cited by 2
Alotaibi, D., Aldagdog, F., Alramadhan, S. I., Almuhaidib, B., Asiri, N., Almodhi, L., Alshabaan, M., Alborhan, R., Vatte, C., Mohiuddin, S. S., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031203 · Cited by 2
Mapping disease loci to biological processes via joint pleiotropic and epigenomic partitioning
Kerner, G., Kamitaki, N., Strober, B. J., & Price, A. L. (2026) · Cell Genomics · doi:10.1016/j.xgen.2025.101138 · Cited by 3
Therapeutic Gene Editing: DNA Repair Pathways, Emerging Editors, and Clinical Progress
Tsai, L., Xiong, Y., Liu, D., Yang, D., Zhang, J., Xu, J., Han, R., & Chen, Y. (2026) · iNew Medicine · doi:10.1002/inm3.70018 · Cited by 1
Self-citationMapping the genetic landscape of suicide risk: Insights from genomic SEM
Yao, K., Zhuo, C., Chen, X., Li, C., Song, H., Zou, J., & Tian, H. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e00852 · Cited by 1
Nucleotide-resolution mapping of regulatory elements via allelic readout of tiled base editing
Becerra, B., Wittibschlager, S., Patel, Z. M., Kutschat, A. P., Delano, J., Che, E., Tauber, A., Wu, T., Starrs, M. M., Horstmann, C. S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69918-8 · Cited by 1
Self-citationNatural History of Chronic Kidney Disease in Sickle Cell Disease
Ataga, K. I. (2026) · American Journal of Hematology · doi:10.1002/ajh.70300 · Cited by 1
Beyond chemotherapy: The rise of nucleic acid nanoformulations in personalized lung cancer therapy
Hermain, S., Harshitha, K. S., & Naveen, N. R. (2026) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2026.04.002 · Cited by 2
Unlocking the curative potential of gene transfer and editing for hematopoietic disorders
Shiroshita, K., Stolz, A., Malouf, C., Tran, V. L., Li, J., Weiss, M. J., & Naldini, L. (2026) · Experimental Hematology · doi:10.1016/j.exphem.2026.105493 · Cited by 1
Reactivation of Fetal Hemoglobin in Thalassemia and Sickle Cell Disease
Eridani, S., Avemaria, F., & Mosca, A. (2014) · Thalassemia Reports · doi:10.4081/thal.2014.2196 · Cited by 1
Top Advances in Functional Genomics and Translational Biology for 2013
Pilbrow, A. P., Arora, P. K., Martinez‐Fernandez, A., Ali, Z. A., Arora, P. K., Chiao, Y. A., Desai, A. A., Gupta, R., Martinez‐Fernandez, A., Perez, M. V., et al. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000521 · Cited by 1
Flansburg, C. N., Balentine, C. M., Grieger, R. W., Lund, J., Ciambella, M., White, D., Coris, E. E., Gonzalez, E. C., Stone, A. C., & Madrigal, L. (2019) · Southern Medical Journal · doi:10.14423/smj.0000000000000976 · Cited by 1
Ropero, P., Peral, M., Sánchez-Martínez, L. J., Rochas, S., Gómez-Álvarez, M., Nieto, J. M., González, F. A., Villegas, A., & Benavente, C. (2023) · ANALES RANM · doi:10.32440/ar.2022.139.03.rev09 · Cited by 1
Robert, S. M., & Rada-Iglesias, Á. (2023) · BioEssays · doi:10.1002/bies.202300038 · Cited by 1
Gene Editing in Hematopoietic Stem Cells
Liao, J., & Wu, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-7471-9_11 · Cited by 2
Genetic Polymorphisms at BcL11A Sites rs10184550 and rs7599488 in Sudanese Sickle Cell Patients
Mustafa, A., Hassan, F. M., Abdelgadir, A., Yousif, M., Elbager, S. G., & Gaffer, A. (2024) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2881 · Cited by 1
Rosean, S., Sosa, E., O’Shea, D., Raj, S. M., Seoighe, C., & Greally, J. M. (2024) · BMC Bioinformatics · doi:10.1186/s12859-024-05794-7 · Cited by 1
Mechanistic and Biological Perspectives on Erythropoiesis
Bresnick, E. H., Papayannopoulou, T., & Migliaccio, A. R. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104286 · Cited by 1
Hotspots and status of Fetal Alpha-Thalassemia from 2009 to 2023: a bibliometric analysis
Li, Q., Li, X., he, S. T., & Li, J. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2024.1467760 · Cited by 1
Gallagher, P. G., Maksimova, Y. D., Schulz, V., & Forget, B. G. (2016) · Hemoglobin · doi:10.1080/03630269.2016.1214921 · Cited by 1
Gentherapie von Hämoglobinkrankheiten – aktuelle Konzepte und Herausforderungen
Kulozik, A. E., & Kunz, J. B. (2019) · Transfusionsmedizin · doi:10.1055/a-0825-9666 · Cited by 2
Kim, J., & Dean, A. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.12.023 · Cited by 1
Liu, L., & Pertsemlidis, A. (2016) · The Medicine Forum · Cited by 1
Interrogation of Enhancer Function by Enhanced CRISPR Epigenetic EditingPreprint
Li, K., Liu, Y., Cao, H., Zhang, Y., Gu, Z., Liu, X., Yu, A., Kaphle, P., Dickerson, K. E., Ni, M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/761247 · Cited by 1
Self-citationGlobin gene regulation for treating β-thalassemias: progress, obstacles and future
Saliba, A. N., Alameddine, R. S., Harb, A., & Taher, A. T. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1074071
Genome Editing in Mice Using TALENs
Aida, T. (2014) · Springer eBooks · doi:10.1007/978-4-431-55227-7_11
Keeping fetal hemoglobin in the loop
Grevet, J. D., & Blobel, G. A. (2014) · Cell Cycle · doi:10.4161/15384101.2014.969995
2014 William Allan Award: A Hematologist’s Pursuit of Hemoglobin Genetics1
Orkin, S. H. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.12.007
Self-citationWakabayashi, A., & Sankaran, V. G. (2015) · Pediatric Research · doi:10.1038/pr.2015.245
Barriers to Effective Genome Editing of Haematopoietic Stem Cells
Howe, S. J., & Milsom, M. D. (2016) · Current Stem Cell Reports · doi:10.1007/s40778-016-0032-x
Finding partners to play the music of regulation
Hardison, R. C. (2016) · Blood · doi:10.1182/blood-2016-02-697169
The long range regulation of breast cancer associated genes
Betts, J. A. (2016) · The University of Queensland · doi:10.14264/uql.2016.158
Anemia-recent Advances in Basic and Clinical Aspects
Komatsu, N. (2015) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.104.1361
Precision Medicine for Sickle Cell Disease: Discovery of Genetic Targets for Drug Development
Pace, B. S., Lopez, N. H., Zhu, X., & Li, Y. (2016) · InTech eBooks · doi:10.5772/64817 · Cited by 1
Elucidation of Mechanisms of Fetal Hemoglobin Regulation by CRISPR/Cas9 Mediated Genome Editing
Canver, M. C. (2016) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Self-citation"T-bet"-ing on autoimmunity variants
Nguyen, M. L. T., Simeonov, D. R., & Marson, A. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006924
Zon, L. I. (2018) · Journal of Clinical Investigation · doi:10.1172/jci124493
A functional characterisation of the PCSK6 locus associated with handedness
Shore, R. (2016) · St Andrews Research Repository (St Andrews Research Repository)
Mannstadt, M., & Wein, M. N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00006-x
CRISPR-Decryptr reveals cis-regulatory elements from noncoding perturbation screensPreprint
Rasmussen, A. W., Äijö, T., Gabitto, M. I., Carriero, N. J., Sanjana, N. E., Skok, J. A., & Bonneau, R. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.13.247007
Sickle cell anemia: HBB haplotypes; clinical heterogeneity; iPSC modeling
Vanuytsel, K., Steinberg, M. H., & Murphy, G. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-822227-0.00002-8
Obeidi, N., Tamaddon, G., Ranjbaran, R., Khamisipour, G., & Saberi, F. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100934
Flipping the Hemoglobin Switch and Discovering Regulators Involved in Fetal Hemoglobin Reactivation
Boontanrart, M. Y. (2020) · eScholarship (California Digital Library)
de Bellefon, S. M., Thibord, F., Auer, P. L., Blangero, J., Coban‐Akdemir, Z., Floyd, J. S., Fornage, M., Johnsen, J. M., Lange, L. A., Lewis, J. P., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.23.394296
Self-citationVoight, B. F. (2021) · Springer eBooks · doi:10.1007/978-3-030-61646-5_7
“Priority delivery” options for gene therapy
Loke, J. C. T. (2021) · Blood · doi:10.1182/blood.2021012761
Rós, F. A. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2021.tde-04102021-161614
Eldin, E. N., Sayed, S. A., Ismail, A. M., Abdellatif, H., Idriss, N. K., & Abd‐Elkader, A. S. (2022) · Journal of Hunan University Natural Sciences · doi:10.55463/issn.1674-2974.49.2.21
Single-dosed exa-cel leads to early and durable increase of foetal haemoglobin
Locatelli, F., & Dooper, M. (2022) · doi:10.55788/35b36a46
Yang, F., Pang, J., Liu, G., Yang, Y., Qin, S., Zhang, Y., Lai, Y., Liang, D., & Wu, Y. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.05.506576
CRISPR/Cas9-Mediated Disruption of Endo16 Cis-Regulatory Elements in Sea Urchin Embryos
Xing, L., Wang, L., Roos, F., Lee, M., & Wray, G. A. (2023) · Fishes · doi:10.3390/fishes8020118
Rivest, J.-F., Carter, S., Goupil, C., Cyr, D., Ung, R., Soglio, D. B. D., Mac‐Way, F., Waters, P. J., Paganelli, M., & Doyon, Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.29.559947
Mumtaz, K., Hussain, I., Iftikhar, F., Rehman, F. U., Jameel, M., Farooq, S., Hassan, H., Fatima, A., Ottmann, O. G., & Mian, A. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.28.568974
Applications of CRISPR/Cas 9 Based Technologies in the Field of Pharmacology: A Traditional Review
Ustaömer, S., & Yaşar, Y. K. (2023) · Journal of Literature Pharmacy Sciences · doi:10.5336/pharmsci.2023-96500
Conventional and Innovative Molecular Approaches Developed for Treating Hemoglobinopathies
Miliotou, Α. N., Georgiou‐Siafis, S. K., Vlachaki, E., Pappas, I. S., Vizirianakis, I. S., Tsiftsoglou, A. S., & Papadopoulou, L. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00025-1
Prasad, M., Choudhuri, A., Yang, S. P., Flynn, E., Zon, L. I., & Zhou, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13222-3.00005-8
Applied Stem Cell Research in Sickle Cell Disease
Kiumarsi, A., Rostami, T., & Mohammadi, M. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00027-5
Gene Editing Approaches for Haematological Disorders
Ferrari, S., & Canarutto, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00053-6
Connecting the dots from let-7 to HIC2 to HBG
Dean, A. (2024) · Blood · doi:10.1182/blood.2024024191 · Cited by 1
Wang, L., He, H., Li, Y., Wang, X., Yu, J., Huang, Y., Yu, K., He, J., Zhao, M., Xie, T., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155717
Genetic variants within silencer elements shape human blood cell phenotype diversityPreprint
Tan, M., van Weerd, J., Yavas, A., & Pang, B. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.13.632723
Metadata
- Authors
- Bauer, D. E., Kamran, S. C., Lessard, S., Xu, J., Fujiwara, Y., Lin, C., Shao, Z., Canver, M. C., Smith, E. C., Pinello, L., Sabo, P. J., Vierstra, J., Voit, R. A., Yuan, G.-C., Porteus, M. H., Stamatoyannopoulos, J. A., Lettre, G., & Orkin, S. H.
- Affiliations
- Boston Children's Hospital (US)
- Howard Hughes Medical Institute (US)
- Montreal Heart Institute (CA)
- Harvard University (US)
- Dana-Farber Cancer Institute (US)
- University of Washington (US)
- Stanford University (US)
- Corresponding author
- Orkin, Stuart H.
- ORCID
- Venue
- Science
- Published
- 2013-10-11
- Volume
- 342
- Issue
- 6155
- Pages
- 253-257
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4018826
- OpenAlex
- W2008989169
- Semantic Scholar
- 2845316815fa241ea105cf77d04cc6906bf4c64b
- Cited by
- 653
- References
- 54
- Citations by year
- 2026: 42 · 2025: 50 · 2024: 64 · 2023: 42 · 2022: 47 · 2021: 48 · 2020: 45 · 2019: 38 · 2018: 49 · 2017: 48 · 2016: 80 · 2015: 59 · 2014: 37 · 2013: 4
- FWCI
- 29.32
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- Canadian Institutes of Health Research (123382)
- National Heart, Lung, and Blood Institute (P01HL032262, R01HL032259)
- National Human Genome Research Institute (U54HG007010, U54HG004594, R01HG005085)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK049216, K08DK093705)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- BCL11A, fetal hemoglobin, common genetic variants, transcription factor binding, fine mapping, erythroid cells, B cells, β-hemoglobinopathies, genome editing
- MeSH terms
- Animals, Carrier Proteins, Cells, Cultured, Chromatin, Chromosome Mapping, Enhancer Elements, Genetic, Fetal Hemoglobin, Gene Expression Regulation, Genetic Engineering, Hemoglobinopathies, Humans, Nuclear Proteins, Repressor Proteins, Transcription Factors, Genetic Variation, Gene Targeting, Erythroid Cells, Cell Line, Tumor, Chromatin Immunoprecipitation, Mice, Precursor Cells, B-Lymphoid, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review